In their follow-up study, the research group identified programmed death ligand 1 (PDL-1)-mediated activation of pro-inflammatory nuclear factor kappa B (NF-κB) signaling as a critical HOTAIR-based therapeutic target against immune tolerance of gliomas (Wang et al. 2021b). The gene discussed is HOTAIR; the disease is glioma.